Pheton (NASDAQ:PTHL) Lowered to “Sell” Rating by Wall Street Zen

Pheton (NASDAQ:PTHL) was downgraded by stock analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Saturday.

Pheton Stock Down 8.5%

PTHL opened at $0.85 on Friday. The business’s 50 day moving average is $7.85 and its 200-day moving average is $7.29. Pheton has a twelve month low of $0.51 and a twelve month high of $32.00.

About Pheton

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors.